RLAY - Relay Therapeutics Inc
10.8
0.110 1.019%
Share volume: 7,425,435
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$10.69
0.11
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-06-2024 | 11-06-2024 | 02-26-2025 | 05-05-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 841.441 M | 772.550 M | 930.115 M | 871.296 M | 799.362 M | 670.000 M | 621.331 M | |
| Current Assets | 770.100 M | 704.270 M | 865.129 M | 809.204 M | 739.659 M | 624.014 M | 578.279 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 20.492 M | 5.732 M | 6.795 M | 10.533 M | 7.352 M | 3.744 M | 5.974 M | |
| Short Term Investments | 20.492 M | 554.290 M | 687.252 M | 657.036 M | 616.813 M | 504.867 M | 470.500 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 749.608 M | 134.125 M | 152.357 M | 124.287 M | 93.542 M | 91.564 M | 84.018 M | |
| Total Non-current Assets | 71.341 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 9.875 M | 8.350 M | 7.210 M | 5.911 M | 5.148 M | 2.359 M | 1.726 M | |
| Other Assets | 56.459 M | 59.930 M | 57.776 M | 56.181 M | 54.555 M | 43.627 M | 41.326 M | |
| Intangible Assets | 2.300 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 841.441 M | 772.550 M | 930.115 M | 871.296 M | 799.362 M | 670.000 M | 621.331 M | |
| Total liabilities | 95.677 M | 90.806 M | 91.254 M | 93.504 M | 78.281 M | 62.291 M | 54.271 M | |
| Total current liabilities | 37.144 M | 45.043 M | 46.968 M | 50.729 M | 37.052 M | 32.605 M | 25.578 M | |
| Accounts Payable | 7.973 M | 11.167 M | 6.867 M | 14.097 M | 8.450 M | 2.752 M | 7.705 M | |
| Other liabilities | 11.374 M | 0.000 | 0.000 | 0.000 | 41.229 M | 0.000 | 0.000 | |
| Current long term debt | 5.147 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 47.159 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 11.374 M | 0.000 | 0.000 | 0.000 | 41.229 M | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 745.764 M | 681.744 M | 838.861 M | 777.792 M | 721.081 M | 607.709 M | 567.060 M | |
| Common stock | 130.843 M | 2.257 B | 2.499 B | 2.517 B | 2.536 B | 2.567 B | 2.581 B | |
| Retained earnings | -1.482 B | -1.574 B | -1.662 B | -1.738 B | -1.815 B | -1.960 B | -2.015 B |